Covid-19 roundup: No­vavax says vac­cine shows 'broad cross-re­ac­tiv­i­ty' against Omi­cron; France can­cels or­der on Mer­ck’s an­tivi­ral pill — re­port

No­vavax said Wednes­day that ini­tial da­ta sug­gest its Covid-19 vac­cine demon­strat­ed “broad cross-re­ac­tiv­i­ty against Omi­cron and oth­er cir­cu­lat­ing vari­ants” af­ter two …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER